Novavax Inc. Stock Slides 9.9%, Underperforms Peers

Dow Jones2026/10/06 20:33

This article was automatically generated by Dow Jones using technology from Automated Insights. Shares of Novavax Inc. shed 9.9% to $11.32 on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index rising 0.4% to 27,599.79 and the Dow Jones Industrial Average rising 0.5% to 51,521.28. Novavax Inc. closed 15.4% below its 52-week high of $13.39, which the company achieved on October 5th. The stock underperformed when compared to some of its peers, as Johnson & Johnson rose 0.7% to $254.78, Pfizer Inc. rose 0.3% to $27.50, and Merck & Co. Inc. rose 1.72% to $141.94. Trading volume totaled 19.3 million, compared to the 50-day average of 5.3 million. Data source: Dow Jones Market Data, FactSet (END) Dow Jones Newswires October 06, 2026 16:33 ET (20:33 GMT)

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

U.S. stocks keep hitting record highs, but tax revenues are falling short, sparking urgency at the IRS.

华尔街见闻•2026/10/07 00:35

October 7 Member Morning Brief: Nvidia Approaches $6 Trillion, EIA Continues to Raise Oil Price Forecasts

华尔街见闻•2026/10/07 00:29

BoJ’s Sato signals support for future rate hikes

FXStreet•2026/10/07 00:09

ETH surpasses $2,700

金色财经•2026/10/07 00:05